60 related articles for article (PubMed ID: 9731491)
1. Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.
Gupta S; Wang Y; Ramos-Garcia R; Shevrin D; Nelson JB; Wang Z
Prostate; 2010 Oct; 70(14):1575-85. PubMed ID: 20564326
[TBL] [Abstract][Full Text] [Related]
2. CYP17 inhibitors for prostate cancer therapy.
Vasaitis TS; Bruno RD; Njar VC
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):23-31. PubMed ID: 21092758
[TBL] [Abstract][Full Text] [Related]
3. In vitro effect of D-004, a lipid extract of the fruit of the cuban royal palm (Roystonea regia), on prostate steroid 5α-reductase activity.
Pérez LY; Menéndez R; Má R; González RM
Curr Ther Res Clin Exp; 2006 Nov; 67(6):396-405. PubMed ID: 24678112
[TBL] [Abstract][Full Text] [Related]
4. Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled "banana-shaped" shell.
Baynes A; Montagut Pino G; Duong GH; Lockyer AE; McDougall C; Jobling S; Routledge EJ
Sci Rep; 2019 Nov; 9(1):16439. PubMed ID: 31712739
[TBL] [Abstract][Full Text] [Related]
5. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system.
Pais P; Villar A; Rull S
Res Rep Urol; 2016; 8():41-9. PubMed ID: 27186566
[TBL] [Abstract][Full Text] [Related]
6. Friedelin, a novel inhibitor of CYP17A1 in prostate cancer from
Joshi BP; Bhandare VV; Vankawala M; Patel P; Patel R; Vyas B; Krishnamurty R
J Biomol Struct Dyn; 2023 Nov; 41(19):9695-9720. PubMed ID: 36373336
[TBL] [Abstract][Full Text] [Related]
7. Association of 5α-Reductase Inhibitor Use With Prostate Cancer-Specific Mortality.
Stroomberg HV; Brasso K; Røder A
JAMA Oncol; 2022 Oct; ():. PubMed ID: 36227624
[No Abstract] [Full Text] [Related]
8. Association of 5α-Reductase Inhibitor Use With Prostate Cancer-Specific Mortality-Reply.
Björnebo L; Eklund M; Lantz A
JAMA Oncol; 2022 Oct; ():. PubMed ID: 36227621
[No Abstract] [Full Text] [Related]
9. A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance.
Zager MG; Barton HA
PLoS One; 2012; 7(9):e44359. PubMed ID: 22970204
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour effects and pharmacokinetic profile of 17-(5'-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesis.
Nnane IP; Long BJ; Ling YZ; Grigoryev DN; Brodie AM
Br J Cancer; 2000 Jul; 83(1):74-82. PubMed ID: 10883671
[TBL] [Abstract][Full Text] [Related]
11. Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo.
Nnane IP; Njar VC; Liu Y; Lu Q; Brodie AM
J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):145-52. PubMed ID: 10659703
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
13. 5alpha-reductase inhibitors/finasteride.
Stoner E
Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
[TBL] [Abstract][Full Text] [Related]
14. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds.
Nnane IP; Kato K; Liu Y; Long BJ; Lu Q; Wang X; Ling YZ; Brodie A
Endocrinology; 1999 Jun; 140(6):2891-7. PubMed ID: 10342882
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]